MTOR and metabolic dysfunction-associated steatotic liver disease: Mechanistic studies have further revealed that IF exerts its protective effects by activating the MIF/AMPK and AMPK/ULK1 signalling pathways, and by inhibiting mTOR phosphorylation, thus regulating autophagy and apoptosis to improve hepatic function in NAFLD [27,29].